Trust in AstraZeneca’s Covid jab falls across the EU amid blood clot fears 

Trust in AstraZeneca’s Covid jab falls across the EU after leaders halted the rollout last week amid blood clot fears Confidence in AstraZeneca’s Covid-19 vaccine has plunged across Europe European leaders paused rollout of jab last week over fears it caused blood clots European Medicines Agency said vaccine was not associated with clotting risk By … Read more

15M in US could be vaccinated if it approved AstraZeneca’s shot

Nearly 15 million more Americans could be fully vaccinated against COVID-19, getting back to work and seeing their families – but millions vials of AstraZeneca’s vaccine are sitting unused in a manufacturing plant.  That’s because the shot – which, along with its highly successful delayed dosing program – that has helped the UK speed ahead … Read more

Astrazeneca’s US Covid vaccine trial to resume

Astrazeneca’s US Covid trial to resume after regulators fail to link patient’s illness with the vaccine By Daily Mail City & Finance Reporter Published: 22:12 BST, 20 October 2020 | Updated: 22:32 BST, 20 October 2020 Astrazeneca’s large, late-stage US trial has been on hold since September 6 Astrazeneca’s Covid-19 vaccine trial in the United … Read more

US widens probe into Astrazeneca’s Covid jab after patient falls ill

US widens probe into Astrazeneca’s Covid jab after patient develops rare spinal disorder during trials By Daily Mail City & Finance Reporter Published: 21:52 BST, 1 October 2020 | Updated: 22:05 BST, 1 October 2020 A probe into how a patient became ill during trials of Astrazeneca’s potential Covid-19 jab has been widened in the … Read more

US regulators are ‘very concerned’ about the side effects of AstraZeneca’s vaccine

US regulators are ‘very concerned’ about the potential side effects of AstraZeneca and Oxford University’s coronavirus vaccine and are debating whether or not to allow the trials to resume. Last week, the trial was put on hold when a British participant was rushed to the hospital after suffering a serious reaction that triggered spinal cord … Read more

Oxford and AstraZeneca’s COVID vaccine trial could restart ‘within days’

Trials of Oxford University’s coronavirus vaccine could be allowed to restart just days after a British volunteer was rushed to hospital with suspected swelling in their spinal cord. UK drug giant AstraZeneca, which owns the rights to the vaccine, announced that all studies of the jab had been paused indefinitely while it investigates whether the … Read more

AstraZeneca’s COVID-19 vaccine trials put on hold after suspected ‘serious’ reaction

BREAKING: Oxford and AstraZeneca’s COVD-19 vaccine trials put on a hold after a UK participant had a ‘serious’ suspected reaction to the leading shot candidate Late stage trials for the vaccine being developed by AstraZeneca and Oxford University have been put on hold  A ‘serious adverse event,’ a possible reaction to the shot was reported … Read more

British drugs giant Astrazeneca’s shares hit record highs

British drugs giant Astrazeneca’s shares hit record highs as it vies with Unilever to be country’s most valuable listed business By Daily Mail City & Finance Reporter Published: 21:50 BST, 24 July 2020 | Updated: 22:07 BST, 24 July 2020 British drugs giant Astrazeneca is having a good year.  Its shares have hit record highs … Read more

Results of Astrazeneca’s Covid-19 vaccine trial due ‘within weeks’

Moment of truth for Astrazeneca: Results of UK drug firm’s Covid-19 vaccine trial due ‘within weeks’ By Matt Oliver For The Daily Mail Published: 21:50 BST, 25 May 2020 | Updated: 22:04 BST, 25 May 2020 Astrazeneca’s bid to produce the world’s first Covid-19 vaccine is facing a moment of truth, with results from a … Read more